首页|异常糖链糖蛋白水平与乳腺癌分子分型及临床病理特征的相关性

异常糖链糖蛋白水平与乳腺癌分子分型及临床病理特征的相关性

扫码查看
目的 探讨乳腺癌中肿瘤异常糖链糖蛋白(tumor abnormal protein,TAP)水平与乳腺癌分子分型、临床病理特征的关系,分析TAP在乳腺癌筛查、诊断和预后中的价值.方法 收集357例乳腺癌患者的临床资料,采集患者肘部静脉血检测TAP凝聚物面积.运用免疫组化EnVision两步法分析AR、ER、PR、HER2、p53、Ki67等表达,应用FISH检测HER2基因,分析TAP表达与乳腺癌临床病理特征、分子分型和临床分期的关系,并复习相关文献.结果 357例乳腺癌患者中,TAP阴性9例(2.52%),TAP弱阳性36例(10.08%),TAP强阳性312例(87.40%),TAP阳性率为97.48%.免疫表型:AR阳性321例、阴性36例,ER阳性256例、阴性101例,PR阳性214例、阴性143例,HER2强阳性98例、弱阳性214例和阴性45例,p53阳性146例、阴性211例,Ki67增殖指数≥20%者276例、<20%者81例.FISH法:155例乳腺癌免疫组化HER2(2+)患者行FISH检测,其中140例阴性,15例阳性.≥50岁患者TAP表达水平明显高于<50岁患者(P<0.05),Ki67增殖指数高表达者的TAP表达水平高于Ki67低表达者(P<0.05).不同分子分型乳腺癌患者的TAP表达差异有统计学意义(P<0.05);三阴型乳腺癌患者的TAP表达高于非三阴型患者(P<0.05),Luminal B型患者的TAP表达高于非Luminal B型患者(P<0.05);不同临床分期的乳腺癌患者TAP表达差异有统计学意义(P<0.05),在乳腺癌中TAP表达水平与临床分期呈正相关.结论 TAP检测可提高乳腺癌诊断准确率,与乳腺癌患者生存率和预后有相关性.
Correlation between tumor abnormal protein level and molecular typing and clinicopathological characteristics in breast cancer
Purpose To investigate the relationship be-tween the level of tumor abnormal protein(TAP)and the molec-ular subtypes and clinicopathological features of breast cancer,and to analyze the value of TAP in breast cancer screening,di-agnosis and prognosis prediction.Methods The clinical data of 357 breast cancer patients were collected,and the elbow venous blood was collected to detect the TAP condensate area.Immuno-histochemical(IHC)EnVision two-step method was used to de-tect the expression of AR,ER,PR,HER2,p53 and Ki67,and FISH to detect HER2 gene.The relationship between TAP ex-pression and clinicopathological features,molecular subtypes and clinical stages of breast cancer was analyzed,and the rele-vant literature was reviewed.Results Among 357 breast cancer patients,9 cases(2.52%)were TAP negative,36 cases(10.08%)were weakly positive,312 cases(87.40%)were strongly positive,and the positive rate of TAP was 97.48%.AR was positive in 321 cases and negative in 36 cases,ER was pos-itive in 256 cases and negative in 101 cases,PR was positive in 214 cases and negative in 143 cases,HER2 was strongly posi-tive in 98 cases,weakly positive in 214 cases and negative in 45 cases,p53 was positive in 146 cases and negative in 211 cases,Ki67 index was ≥20%in 276 cases and<20%in 81 case.A total of 155 cases of IHC HER2(2+)breast cancer were tested by FISH:140 cases were negative and 15 cases were positive.The expression level of TAP in patients of ≥50 years old expres-sionas significantly higher than that in patients of<50 years old(P<0.05).The expression level of TAP in patients with high Ki67 proliferation index was significantly higher than that in pa-tients with low Ki67 proliferation index(P<0.05).There was a significant difference in TAP expression between patients with different molecular subtypes(P<0.05).Tap expression was higher in triple-negative breast cancer patients than in non-tri-ple-negative breast cancer patients(P<0.05),and it was high-er in Luminal B breast cancer patients than in non-Luminal B breast cancer patients(P<0.05).There was a significant difference in TAP expression between patients with different clin-ical stages(P<0.05),and TAP expression level was positively correlated with clinical stage in breast cancer.Conclusion TAP detection can improve the diagnostic accuracy of breast cancer,and has a certain correlation with the survival rate and prognosis of breast cancer patients.

breast neoplasmmolecular typingtumor abnor-mal glycoproteinclinicopathological characteristics

李云婷、董晓彤、高建芳、张云香

展开 >

山东第二医科大学第一附属医院/潍坊市人民医院精准病理诊断中心,潍坊 261041

乳腺肿瘤 分子分型 肿瘤异常糖链糖蛋白 临床病理特征

山东省自然科学基金潍坊市科技发展项目

ZR2023MH0642022YX001

2024

临床与实验病理学杂志
安徽医科大学,中华医学会安徽分会

临床与实验病理学杂志

CSTPCD北大核心
影响因子:0.776
ISSN:1001-7399
年,卷(期):2024.40(3)
  • 20